A higher expression of claudin-10 was also observed in several carcinomas, such as HCC [35], papillary thyroid cancer [37], and biliary tract cancers [38], and was correlated with a shorter overall survival in HCC [35]. Here, CLDN10 is linked to hepatocellular carcinoma.